Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stoneville Pedigreed Seed Company is a leading developer of high-performance cotton seeds and advanced genetic traits, primarily serving the North American agricultural market. Founded in 1922 in Stoneville, Mississippi, the company has established a century-long legacy in cotton breeding, focusing on varieties that offer high yield potential and superior fiber properties. Its product portfolio integrates cutting-edge biotechnology, including traits for multi-mode insect resistance and tolerance to various herbicides such as glyphosate, glufosinate, and dicamba. Following a complex history of ownership involving Monsanto and Bayer, Stoneville was acquired by BASF in 2018. Today, it operates as a flagship brand within BASF's Agricultural Solutions division, continuing to innovate in germplasm development and pest management technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stoneville Pedigreed Seed Company.